A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
Clinical trial NCT00924989 · COMPLETED
Trial details
- NCT number
- NCT00924989
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2012-07-11
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.